**Stapolin-CV** combines Cefpodoxime Proxetil and Potassium Clavulanate in tablet form, enhancing antibacterial efficacy. Cefpodoxime, a third-generation cephalosporin, inhibits bacterial cell wall synthesis, while Clavulanate, a beta-lactamase inhibitor, protects Cefpodoxime from degradation. This synergy effectively treats various infections, including those of the respiratory and urinary tracts. Follow medical advice on dosage and duration to ensure optimal results and prevent antibiotic resistance.Available in PCD pharma franchise and Third Party manufacturing in saturn formulations